Pricing Log in Create free account

Edesa Biotech, Inc. (EDSA) vs NanoViricides, Inc. (NNVC)

Edesa Biotech, Inc. and NanoViricides, Inc. are both Biotechnology companies. Edesa Biotech, Inc. and NanoViricides, Inc. are of similar size ($36.1M and $35.0M). Across the 9 metrics below, NanoViricides, Inc. leads on 7 and Edesa Biotech, Inc. on 2.

Valuation

Metric EDSA NNVC Biotechnology median
P/E n/m n/m 8.50
P/S 70.40 n/m 9.71
P/B 58.02 3.21 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 38.98 n/m 9.21
Earnings yield (65.76%) (28.89%) (33.15%)
Free cash flow yield (38.51%) (27.93%) (25.50%)

Profitability

Metric EDSA NNVC Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (531.32%) (101.46%) (56.36%)
Return on assets (102.46%) (87.91%) (48.04%)
Return on invested capital 0.00% (88.16%) 0.00%

Growth

Metric EDSA NNVC Biotechnology median
Revenue growth (TTM) (43.48%) — 6.02%
EPS growth (last fiscal year) 34.20% 35.38% 30.26%
Revenue growth, 5-year CAGR (15.40%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EDSA NNVC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.76 2.66 4.72
Net debt to EBITDA 1.39 0.36 0.96

Dividend

Metric EDSA NNVC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EDSA NNVC Biotechnology median
Market cap 36.08m 34.97m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack